What They Do
Allele Biotech develops iPS cell–based therapies, advanced assay and cell models, and high-performance research tools, leveraging proprietary reprogramming, gene modification, and fluorescent sensor technologies.
Value Creation
Specific value-creation activities are selectively disclosed in alignment with company and partner confidentiality.
Milestones & Achievements
2025 — Awarded U.S. patent for antibody and T-cell receptor fragment identification method
2025 — Awarded U.S. patent for stem cell-based β-cell differentiation method
2024 — Partnered with the California Institute for Regenerative Medicine (CIRM) to accelerate regenerative medicine product development
2024 — Entered licensing agreement with K Pharma to develop regenerative medicine products
2024 — Launched NIH-funded collaboration with Cellular Logistics to advance regenerative medicine development
